ROKK Solutions has hired John Brandt as VP of public affairs. Brandt comes to ROKK from the Public Affairs Council, where he was manager of policy communications and corporate responsibility. He previously served as associate director for communications at the Graduate School of Political Management at George Washington University, and spent eight years as a producer at the Fox News Channel, with a focus on Capitol Hill coverage. “John is a well-seasoned and innovative communicator. He has a penchant for being ahead of the curve in how to best reach audiences, which will be invaluable to our clients,” said ROKK Solutions partner Rodell Mollineau.
Infinite Global has promoted Sophie Cikovsky and Jesse Dungan to vice president. Cikovsky and Dungan are both based in the firm’s San Francisco office. Cikovsky has been with the firm since 2012, most recently serving as associate vice president. Before that, she was senior client supervisor and U.S. operations manager. She has counseled companies on media relations, internal communications, branding and social media strategies as well as working with clients in the legal industry. Dungan has been at Infinite Global since 2011, serving as associate vice president and director of media strategy. Before coming to the firm, he was a reporter for Daily News Group and the Bay City News Service. He is an account lead for a number of national and global clients, and is a key member on Infinite Global’s pro bono accounts. Dungan currently leads a team advising a San Francisco-based organization dedicated to breaking the cycles of homelessness and domestic violence in the city.
Applied DNA Sciences has appointed Sanjay Hurry executive director of investor relations and corporate communications. Hurry comes to Applied DNA Sciences from LHA Investor Relations (the company’s agency of record), where he was vice president. He was previously the owner of NaniVentures IR Consulting. In his new role, Hurry will oversee Applied DNA Sciences’ outreach with the investment community and report to chairman, president and CEO James A. Hayward. “His demonstrated success in building strategic communications programs that support business growth, and deep understanding of Applied DNA’s business, will be key to helping us broaden Wall Street’s awareness of our proprietary PCR-based linear DNA manufacturing platform,” Hayward said.
No comments have been submitted for this story yet.